Figure 1From: High HbA1c levels correlate with reduced plaque regression during statin treatment in patients with stable coronary artery disease: Results of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS)Associations between HbA1c and plaque volume change. Associations in all patients (a), in patients with diabetes mellitus (b), and in non-diabetic patients (c).Back to article page